Back to Browse Journals » International Journal of Nanomedicine » Volume 1 » Issue 4

Nanocrystalline silver dressings in wound management: a review

Authors Joy Fong, Fiona Wood

Published Date February 2006 Volume 2006:1(4) Pages 441—449

DOI http://dx.doi.org/

Published 24 February 2006

Joy Fong1, Fiona Wood2
 
1Burns Unit, Burns Service, Royal Perth Hospital, west Australia 2Burns Service, Royal Perth Hospital/Princess Margaret Hospital, west Australia
Abstract: This paper describes the properties of nanocrystalline silver products (Acticoat™) and their applications and examines available evidence supporting their use in wound management. Acticoat utilizes nanotechnology to release nanocrystalline silver crystals. Acticoat releases 30 times less silver cations than silversulfadiazine cream or 0.5% silver nitrate solution but more of the silver released (by Acticoat). Silver-impregnated slow-release dressings release minute concentrations of silver which are quickly bound up by the chloride in the wound exudate. While extrapolations from in vitro and animal studies are cautious, evidence from these studies suggests Acticoat is: effective against most common strains of wound pathogens; can be used as a protective covering over skin grafts; has a broader antibiotic spectrum activity; and is toxic to keratinocytes and fibroblasts. Animal studies suggest a role for nanocrystalline silver in altering wound inflammatory events and facilitation of the early phase of wound healing. Quality human clinical trials into nanocrystalline silver are few. However, evidence suggests using Acticoat in wound management is cost effective, reduces wound infection, decreases the frequency of dressing changes and pain levels, decreases matrix metalloproteinase activity, wound exudate and bioburden levels, and promotes wound healing in chronic wounds. Although there is no in vivo evidence to suggest nanocrystalline silver is toxic to human keratinocytes and fibroblasts, there is in vitro evidence to suggest so; thus these dressings should be used cautiously over epithelializing and proliferating wounds. Future clinical research, preferably randomized controlled trials into nanocrystalline silver technology, may provide clinicians a better understanding of its applications in wound management.
Keywords: nanocrystalline, silver, burns, chronic, wounds, dressings

Download Article [PDF] 

Readers of this article also read:

Sodium valproate-induced enuresis in a pediatric bipolar patient

Cheng W, Lin X, Lu D

Neuropsychiatric Disease and Treatment 2013, 9:1671-1672

Published Date: 31 October 2013

Novel nanostructured biomaterials: implications for coronary stent thrombosis

Karagkiozaki V, Karagiannidis PG, Kalfagiannis N, Kavatzikidou P, Patsalas P, Georgiou D, Logothetidis S

International Journal of Nanomedicine 2012, 7:6063-6076

Published Date: 17 December 2012

Pattern sensitivity: a missed part of the diagnosis

El Shakankiry HM, Abdel Kader AA

Neuropsychiatric Disease and Treatment 2012, 8:313-319

Published Date: 17 July 2012

Is this a new type of primary prosopagnosia, both progressive and apperceptive?

Sugimoto A, Koyama S, Midorikawa A, Futamura A, Ishiwata K, Ishii K, Miller MW, Kawamura M

Neuropsychiatric Disease and Treatment 2012, 8:169-173

Published Date: 18 April 2012

Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome

Leahy JT, Chu-Shore CJ, Fisher JL

Neuropsychiatric Disease and Treatment 2011, 7:673-681

Published Date: 11 November 2011

The increasing burden of depression

Lépine J-P, Briley M

Neuropsychiatric Disease and Treatment 2011, 7:3-7

Published Date: 31 May 2011

The relationship between insomnia and depressive symptoms: genuine or artifact?

Fadia Isaac, Kenneth Mark Greenwood

Neuropsychiatric Disease and Treatment 2011, 7:57-63

Published Date: 14 February 2011

Gene promoter hypermethylation in leukoplakia of the oral mucosa

Mingli Liu, Lei Feng, Ximing Tang, et al

Pathology and Laboratory Medicine International 2010, 2:71-77

Published Date: 7 July 2010

Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy

Xiang-Hong Peng, Ximei Qian, Hui Mao, Andrew Y Wang, Zhuo (Georgia) Chen, et al

International Journal of Nanomedicine 2008, 3:311-321

Published Date: 9 October 2008

Depression and smoking cessation: Does the evidence support psychiatric practice?

Anna Lembke, Kenasha Johnson, Charles DeBattista

Neuropsychiatric Disease and Treatment 2007, 3:487-493

Published Date: 8 October 2007